Frequency and phenotype of human circulating and intrahepatic natural killer cell subsets is differentially regulated according to stage of chronic liver disease

Digestion

Volumn 88, Issue 1, 2013, Pages 1-16

  Zimmermann, Henning Wolfgang ^a   Mueller, Jan Robert ^a   Seidler, Sebastian ^a   Luedde, Tom ^a   Trautwein, Christian ^a   Tacke, Frank ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Innate immunity; Liver cirrhosis; Liver fibrosis; Natural killer cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; CD16 ANTIGEN; C REACTIVE PROTEIN; CD19 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CHOLINESTERASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROCOLLAGEN; PROTEIN; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASCITES; AUTOIMMUNE LIVER DISEASE; BILIRUBIN BLOOD LEVEL; CELL ISOLATION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; END STAGE LIVER DISEASE; ESOPHAGUS VARICES; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE FREQUENCY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; VIRUS HEPATITIS; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FIBROGENESIS; HELPER CELL; LEUKOCYTE COUNT; LIVER FUNCTION; NATURAL KILLER T CELL; SODIUM BLOOD LEVEL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHRONIC DISEASE; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LIVER CIRRHOSIS; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84878938696     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000350821     Document Type: Article

References (42)

1. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655- 1669. (Pubitemid 351615417)
2. Marra F, Aleffi S, Galastri S, Provenzano A: Mononuclear cells in liver fibrosis. Semin Immunopathol 2009; 31: 345-358.
3. Iredale JP: Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007; 117: 539-548. (Pubitemid 46348508)
4. Zimmermann HW, Tacke F: Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Inflamm Allergy Drug Targets 2011; 10: 509-536.
5. Muhanna N, Abu Tair L, Doron S, Amer J, Azzeh M, Mahamid M, Friedman S, Safadi R: Amelioration of hepatic fibrosis by NK cell activation. Gut 2011; 60: 90-98.
6. Melhem A, Muhanna N, Bishara A, Alvarez CE, Ilan Y, Bishara T, Horani A, Nassar M, Friedman SL, Safadi R: Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol 2006; 45: 60-71. (Pubitemid 43850614)
7. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B: Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor- related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006; 130: 435-452. (Pubitemid 43202042)
8. Gur C, Doron S, Kfir-Erenfeld S, Horwitz E, Abu-Tair L, Safadi R, Mandelboim O: NKp46- mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 2012; 61: 885-893.
9. Klugewitz K, Adams DH, Emoto M, Eulenburg K, Hamann A: The composition of intrahepatic lymphocytes: shaped by selective recruitment? Trends Immunol 2004; 25: 590- 594. (Pubitemid 39369735)
10. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW: Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134: 657- 667.
11. Sun R, Gao B: Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-γ). Gastroenterology 2004; 127: 1525-1539. (Pubitemid 39457777)
12. Caligiuri MA: Human natural killer cells. Blood 2008; 112: 461-469.
13. Orange JS, Ballas ZK: Natural killer cells in human health and disease. Clin Immunol 2006; 118: 1-10. (Pubitemid 43012040)
14. Shi FD, Ljunggren HG, La Cava A, Van Kaer L: Organ-specific features of natural killer cells. Nat Rev Immunol 2011; 11: 658-671.
15. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-640. (Pubitemid 33043908)
16. Fauriat C, Long EO, Ljunggren HG, Bryceson YT: Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010; 115: 2167-2176.
17. Morishima C, Paschal DM, Wang CC, Yoshihara CS, Wood BL, Yeo AE, Emerson SS, Shuhart MC, Gretch DR: Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 2006; 43: 573-580.
18. Lee S, Watson MW, Flexman JP, Cheng W, Hammond T, Price P: Increased proportion of the CD56 bright NK cell subset in patients chronically infected with hepatitis C virus receiving interferon-α and ribavirin therapy. J Med Virol 2010; 82: 568-574.
19. Golden-Mason L, Madrigal-Estebas L, Mc- Grath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, Doherty DG: Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 2008; 57: 1121-1128.
20. Pernollet M, Jouvin-Marche E, Leroy V, Vigan I, Zarski JP, Marche PN: Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions. Clin Exp Immunol 2002; 130: 518-525. (Pubitemid 35418337)
21. Gonzalez VD, Falconer K, Michaelsson J, Moll M, Reichard O, Alaeus A, Sandberg JK: Expansion of CD56 - NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFN-α and ribavirin. Clin Immunol 2008; 128: 46-56.
22. Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A, Tischendorf JJ, Luedde T, Weiskirchen R, Trautwein C, Tacke F: Functional contribution of elevated circulating and hepatic nonclassical cd14cd16 monocytes to inflammation and human liver fibrosis. PLoS One 2010; 5:e11049.
23. Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, Tacke F: Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 2011; 6:e21381.
24. Tacke F, Brabant G, Kruck E, Horn R, Schoffski P, Hecker H, Manns MP, Trautwein C: Ghrelin in chronic liver disease. J Hepatol 2003; 38: 447-454. (Pubitemid 36399247)
25. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520. (Pubitemid 24166476)
26. Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F: Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol 2010; 11: 30.
27. Phillips JH, Le AM, Lanier LL: Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. J Exp Med 1984; 159: 993-1008. (Pubitemid 14171615)
28. Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, Gazit R, Joseph A, Schjetne KW, Steinle A, Porgador A, Mevorach D, Goldman-Wohl D, Yagel S, LaBarre MJ, Buckner JH, Mandelboim O: Novel APClike properties of human NK cells directly regulate T-cell activation. J Clin Invest 2004; 114: 1612-1623. (Pubitemid 40385552)
29. McGovern BH, Golan Y, Lopez M, Pratt D, Lawton A, Moore G, Epstein M, Knox TA: The impact of cirrhosis on CD4+ T-cell counts in HIV-seronegative patients. Clin Infect Dis 2007; 44: 431-437. (Pubitemid 46147629)
30. Gur C, Doron S, Kfir-Erenfeld S, Horwitz E, Abu-Tair L, Safadi R, Mandelboim O: NKp46- mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 2012; 61: 885-893.
31. Glassner A, Eisenhardt M, Kramer B, Korner C, Coenen M, Sauerbruch T, Spengler U, Nattermann J: NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in aTRAIL-, FASL- and NKG2D-dependent manner. Lab Invest 2012; 92: 967-977.
32. Kramer B, Korner C, Kebschull M, Glassner A, Eisenhardt M, Nischalke HD, Alexander M, Sauerbruch T, Spengler U, Nattermann J: Natural killer p46 high expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. Hepatology 2012; 56: 1201-1213.
33. Eisenhardt M Glassner A Kramer B Korner C Sibbing B Kokordelis P Nischalke HD Sauerbruch T Spengler U Nattermann J The CXCR3 + CD56 bright phenotype characterizes a Distinct Nk Cell Subset With Anti-fibrotic Potential That Shows Dysregulated Activity In Hepatitis C. PLoS One 2012; 7e38846
34. Bonavita MS, Franco A, Paroli M, Santilio I, Benvenuto R, De Petrillo G, Levrero M, Perrone A, Balsano C, Barnaba V: Normalization of depressed natural killer activity after interferon-α therapy is associated with a low frequency of relapse in patients with chronic hepatitis C. Int J Tissue React 1993; 15: 11-16. (Pubitemid 23308561)
35. Meier UC, Owen RE, Taylor E, Worth A, Naoumov N, Willberg C, Tang K, Newton P,Pellegrino P, Williams I, Klenerman P, Borrow P: Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 2005; 79: 12365-12374. (Pubitemid 41346098)
36. Corado J, Toro F, Rivera H, Bianco NE, Deibis L, De Sanctis JB: Impairment of natural killer cytotoxic activity in hepatitis C virus infection.Clin Exp Immunol 1997; 109: 451-457. (Pubitemid 27402312)
37. Par G, Rukavina D, Podack ER, Horanyi M, Szekeres-Bartho J, Hegedus G, Paal M, Szereday L, Mozsik G, Par A: Decrease in CD3-negative- CD8dim + and Vδ2/Vγ TCR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J Hepatol 2002; 37: 514-522.
38. Duesberg U, Schneiders AM, Flieger D, Inchauspe G, Sauerbruch T, Spengler U: Natural cytotoxicity and antibody-dependent cellula cytotoxicity is not impaired in patients suffering from chronic hepatitis C. J Hepatol 2001; 35: 650-657 (Pubitemid 33078276)
39. Tian Z, Chen Y, Gao B: Natural killer cells in liver disease. Hepatology 2013; 57: 1654- 1662.
40. Kahraman A, Schlattjan M, Kocabayoglu P, Yildiz-Meziletoglu S, Schlensak M, Fingas CD, Wedemeyer I, Marquitan G, Gieseler RK, Baba HA, Gerken G, Canbay A: Major histocompatibility complex class I-related chainsA and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. Hepatology 2010; 51: 92- 102.
41. Shimoda S, Harada K, Niiro H, Shirabe K, Taketomi A, Maehara Y, Tsuneyama K, Nakanuma Y, Leung P, Ansari AA, Gershwin 0ME, Akashi K: Interaction between toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis. Hepatology 2011; 53: 1270-1281.
42. Shimoda S, Tsuneyama K, Kikuchi K, Harada K, Nakanuma Y, Nakamura M, Ishibashi H, Hisamoto S, Niiro H, Leung PS, Ansari AA, Gershwin ME, Akashi K: The role of natural killer (NK) and NK T cells in the loss of toleranc in murine primary biliary cirrhosis. Clin Exp Immunol 2012; 168: 279-284.